Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Method for preparing glycan-negative ion polysaccharide compound nanoparticles from micro-emulsions

An anionic polysaccharide and nano-microsphere technology, applied in the field of medicine, can solve the problems of large particle size, irregular particle shape, restriction of protein drug release, etc. The effect of highly uniform spherical particle size distribution

Active Publication Date: 2015-05-20
广州铂思雅生物医药科技有限公司
View PDF1 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] At present, the preparation technology of using the electrostatic complex of chitosan and anionic polysaccharide as the carrier of oral protein drugs or other active ingredients mainly adopts the method of mixing and stirring the two solutions to prepare composite carrier particles. The defect of this method is that the obtained Large particle size (above micron), extremely wide range of particle size distribution, and irregular particle shape, thus limiting the release of protein drugs

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Method for preparing glycan-negative ion polysaccharide compound nanoparticles from micro-emulsions

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0037] Example 2

Embodiment 2

[0039] Example 3

Embodiment 3

[0041] Example 4

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
particle sizeaaaaaaaaaa
particle sizeaaaaaaaaaa
particle sizeaaaaaaaaaa
Login to View More

Abstract

The invention relates to the field of medicines, and particularly relates to a method for preparing glycan-negative ion polysaccharide compound nanoparticles from micro-emulsions. According to the method, chitosan and negative ion polysaccharide are subjected to electrostatic interaction in a water / oil micro-emulsion to form compound polysaccharide nanoparticles, and more specifically, firstly a chitosan micro-emulsion and a negative ion polysaccharide micro-emulsion are prepared, and then are fixed and stirred, wherein the oil phase of the chitosan micro-emulsion is limonene. The invention provides an electrostatic compound nanoparticle carrier formed by the chitosan and other natural negative ion polysaccharide, wherein the average particle size of the carrier does not exceed 300nm, the particle size distribution are uniform, and the carrier can be used for intestinal tract targeted delivery of oral protein medicines, gene medicines and food natural activity products.

Description

technical field [0001] The invention relates to the field of medicine, in particular to a method for preparing chitosan-anionic polysaccharide composite nano microspheres by microemulsion. Background technique [0002] After oral administration, protein drugs are hydrolyzed by gastric acid and catalyzed by enzymes in the gastrointestinal tract, and are not easy to pass through barriers such as the gastrointestinal mucosa, resulting in extremely low bioavailability. In order to successfully deliver protein drugs orally, they must be protected against the harsh environment of the stomach, avoiding hydrolysis and enzymatic degradation of protein drugs, and at the same time, the permeability of protein drugs to the intestinal mucosa needs to be increased. [0003] Some synthetic polymers such as polylactic acid, poly-2-oxyacid, etc. are used to embed protein drugs, but the synthesis of polymers requires a harsh environment, which is likely to cause denaturation of protein drugs;...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C08J3/09C08L5/08C08L5/00C08L5/04A61K47/36A61K9/14A61K48/00A23L1/09
Inventor 胡坤高永清招原春黄永梨岑碧敏郑洋洋苏剑峰文扬飞邓丽青
Owner 广州铂思雅生物医药科技有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products